In the realm of professional sports, where the glory of victory often comes at the cost of physical toll, the need for advanced medical support is ever-present. The UFC, the global leader in the world of mixed martial arts, has recognized this and taken a monumental step forward by partnering with Cellular Performance Institute (CPI) Stem Cells, heralding a new era in athlete care.

A Pioneering Move in Combat Sports

This partnership is historic, positioning the UFC as the first major sports league to integrate stem cell therapy at such a comprehensive level. CPI, a leader in regenerative medicine, brings to the table cutting-edge therapies developed through pioneering research. Known for their potential to accelerate healing, enhance tissue regeneration, and reduce the risk of career-threatening injuries, CPI’s stem cell treatments are about to become a cornerstone of athlete care within UFC’s rigorous training and recovery protocols.

As Ed Clay, co-founder of CPI and also ironically the founder of Pro MMA Now, explains, “This partnership isn’t just a progression; it’s a revolution in athlete health management.” Clay’s dual involvement in both CPI and Pro MMA Now provides a unique insider perspective on how transformative this partnership will be for the fighters and the sport itself.

Pro MMA Now has been covering the sport of mixed martial arts and the UFC since 2008. Clay’s leadership with the brand helped elevate it to the level where a partnership was formed with USA Today Sports and a global media team was formed that covered the sport of MMA in depth from the regional scene to the UFC.

“Knowing Ed Clay is at the helm of this partnership between CPI and the UFC assures me the athletes are the real winners here,” Pro MMA Now co-founder Jack Bratcher said. “Having known Ed for a long time and seeing first hand what he’s been able to accomplish inside and outside the MMA space has been a real joy. Whatever he gets involved with it’s because of his passion, and having also been a coach and fighter himself, he understands the physical and mental challenges the athletes endure. This seems like a perfect fit.”

Not All Stem Cells are The Same, The CPI Difference

CPI has a revolutionary approach to regenerative medicine by utilizing Hypoxic Mesenchymal Stem Cells (MSCs), a game-changer not readily available in the United States. Unlike conventional stem cell therapies, which source stem cells from bone marrow or fat, CPI cultivates MSCs under low-oxygen conditions, mimicking the natural environment of human tissues. This unique process enhances the survival and functionality of MSCs, significantly boosting their efficacy in driving tissue repair and regeneration.

The CPI Difference stems from the exclusivity of hypoxic MSCs. This innovative approach harnesses the superior qualities of hypoxic MSCs, including their heightened secretion of paracrine factors, enhanced homing capabilities, and stronger immunomodulatory effects. 

Enhancing Care, Optimizing Performance

Grant Norris-Jones, Executive Vice President of UFC & WWE, emphasizes the significance of this collaboration, stating, “With CPI’s advanced stem cell therapies, we are now equipped to offer our athletes unprecedented care, aiding faster recovery and extending their careers without the typical fears of long-term injury.”

The implications of this partnership ripple out beyond the immediate benefits to UFC athletes. By embracing such advanced medical technology, UFC is setting a new standard of care that other sports organizations will likely look to emulate. It marks a shift towards a future where the integration of cutting-edge medical treatments with athlete training regimens is the norm, promoting not only better performance but also enhanced long-term health.

A Celebration of Innovation at UFC 300

The official rollout of this partnership will be showcased at UFC 300: PEREIRA vs. HILL, set to take place on April 13 at the T-Mobile Arena in Las Vegas. This event, already a landmark in the history of combat sports, will also serve as the celebration of UFC’s commitment to advancing athlete care through innovative partnerships. Athletes stepping into the octagon will now have the backing of not just their coaches and trainers but also the leading science in regenerative medicine.

As the fighters prepare for their bouts, behind the scenes, the impact of CPI’s stem cell therapies is already being felt. Early reports from training camps speak to quicker recovery times and athletes feeling in peak condition, showcasing the immediate benefits of this partnership.

Looking Forward: The Future of Athlete Health and Performance

Looking to the future, the partnership between CPI Stem Cells and UFC is expected to not only reshape the approach to medical care in sports but also act as a catalyst for further research and development in regenerative medicine. This collaboration could potentially open new avenues for treating a wide range of conditions, benefiting not only athletes but society as a whole.

This is just the beginning. As UFC continues to push the boundaries of what’s possible within the realm of athlete health and performance, the possibilities are limitless. With the support of CPI’s stem cell therapies, the future of combat sports looks brighter and more promising than ever, setting a new benchmark for how athletes are cared for in the high-stakes world of professional sports.

Pro MMA Now is honored to cover this innovative journey, particularly given Ed Clay’s role in making this partnership a reality. As we continue to provide cutting-edge coverage of MMA, stay tuned for more updates on how this partnership develops and leads the way in sports health innovation.

To learn more about CPI Stem cells and the therapies they offer visit or call +1 (855) 227-1411